|
1. Hsu SJ, Huang HC, Pun CK, Chang CC, Chuang CL, Huang YH, Hou MC, Lee FY. Sodium-glucose cotransporter-2 inhibition exacerbates hepatic encephalopathy in biliary cirrhotic rats. J Pharmacol Exp Ther 2022:JPET-AR-2022-001289.
2. Huang HC, Ho HL, Chang CC, Chuang CL, Pun CK, Lee FY, Huang YH, Hou MC, Hsu SJ. Matrix metalloproteinase-9 inhibition or deletion attenuates portal hypertension in rodents. J Cell Mol Med 2021;25:10073-10087.
3. Huang HC, Tsai MH, Chang CC, Pun CK, Huang YH, Hou MC, Lee FY, Hsu SJ. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats. Clin Sci (Lond) 2021;135:2709-2728.
4. Hsin IF, Huang HC, Chang CC, Hsu SJ, Lee FY, Huo TI, Chuang CL, Hou MC, Lee SD. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes. Clin Sci (Lond) 2018;132:2391-2405.
5. Hsu SJ, Tsai MH, Chang CC, Hsieh YH, Huang HC, Lee FY, Chuang CL, Hou MC, Lee SD. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution. Clin Sci (Lond) 2018;132:669-683.
|